Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Microcirculation ; 23(1): 53-61, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26749451

ABSTRACT

OBJECTIVES: To determine the effects of six months alfacalcidol on microvascular endothelial function, arterial stiffness, and BP in DN patients. METHODS: Twenty-eight DN patients on alfacalcidol, 0.25 µg daily for six months were compared to 32 controls on conventional treatment. Measurements of microvascular endothelial function, arterial stiffness [AIx and PWV], hsCRP, and BP were performed; differences between baseline and six months treatment were evaluated. RESULTS: No difference was seen in microvascular endothelial function for both groups after six months. Improvement in CSBP (p = 0.027) with trends of improvement in AIx (p = 0.063), PWV (p = 0.075), and systolic BP (p = 0.088) were seen in the alfacalcidol group with no changes observed in controls. Subgroup analysis of alfacalcidol group showed that vitamin D-deficient patients had better response to treatment. hsCRP level remained unchanged in alfacalcidol group; significant increase was however seen in controls. CONCLUSION: Alfacalcidol did not have an effect on microvascular endothelial function in DN patients. Alfacalcidol significantly improved CSBP with trends of improvement in arterial stiffness and peripheral BP. Alfacalcidol appears to be more beneficial in vitamin D-deficient patients.


Subject(s)
Blood Pressure/drug effects , Diabetes Mellitus, Type 2 , Diabetic Nephropathies , Endothelium, Vascular/physiopathology , Hydroxycholecalciferols/administration & dosage , Vascular Stiffness/drug effects , Adult , Aged , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/physiopathology , Diabetic Nephropathies/drug therapy , Diabetic Nephropathies/physiopathology , Female , Humans , Male , Middle Aged , Vitamin D Deficiency/drug therapy , Vitamin D Deficiency/physiopathology
2.
Intern Med ; 50(16): 1765-8, 2011.
Article in English | MEDLINE | ID: mdl-21841342

ABSTRACT

We report a case of renal tubular acidosis (RTA) in a patient with HIV infection and AIDS. A 33-year-old HIV-positive man with Hepatitis C and tuberculous lymphadenitis was admitted due to deep venous thrombosis and generalized muscle weakness. He had never received anti-retroviral medication. The blood gases and serum electrolytes showed hyperchloremic normal anion gap metabolic acidosis with severe hypokalemia and alkaline urine. Diagnosis of distal RTA was made. His renal function and serum globulin level remained within normal range throughout his illness. Clinicians should be alert to renal tubular disorders in HIV/AIDS patients even in the absence of anti-retroviral therapy or hypergammaglobulinemic state.


Subject(s)
Acidosis, Renal Tubular/complications , Acidosis, Renal Tubular/diagnosis , HIV Infections/complications , HIV Infections/diagnosis , Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/diagnosis , Adult , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...